CX3CR1 and neoplasm: Other chemokine receptor targets under investigation included CX3CR1 [82], CXCR5 [83], etc. The research has indicated that CAR-T cells overexpressing chemokine receptors exhibited enhanced tumor infiltration capability and lower off-tumor, on-target toxicity.